Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2384 |
Pomalidomide
CC-4047,泊马度胺 |
Apoptosis; TNF; Ligand for E3 Ligase; Molecular Glues | Apoptosis; PROTAC |
Pomalidomide (CC-4047) 是一种抗血管生成剂和免疫调节剂,以分子胶的方式作用。它与 E3 连接酶 cereblon 相互作用,诱导必需的 Ikaros 转录因子的降解。 | |||
T40025 |
Pomalidomide-PEG2-CO2H
Pomalidomide 4'-PEG2-acid,Pomalidomide-PEG2-C2-acid |
E3 Ligase Ligand-Linker Conjugate | PROTAC |
Pomalidomide-PEG2-CO2H 是一种合成的 E3 连接酶配体-接头偶联物,包含基于 Pomalidomide 的 cereblon 配体和 2 单元 PEG 接头。 | |||
T40024 |
Pomalidomide-PEG1-CO2H
Pomalidomide-PEG1-C2-COOH |
E3 Ligase Ligand-Linker Conjugate | PROTAC |
Pomalidomide-PEG1-CO2H 是一种合成的 E3 连接酶配体-接头偶联物,包含基于 Pomalidomide 的 cereblon 配体和 2 单元 PEG 接头。 | |||
T40007 |
Pomalidomide-C5-COOH
|
Others | Others |
Pomalidomide-C5-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40009 |
Pomalidomide-C4-COOH
|
Others | Others |
Pomalidomide-C4-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40001 |
Pomalidomide-C6-COOH
|
Others | Others |
Pomalidomide-C6-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40014 |
Pomalidomide-C4-OH
|
Others | Others |
Pomalidomide-C4-OH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40005 |
Pomalidomide-C2-COOH
|
Others | Others |
Pomalidomide-C2-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40020 |
Pomalidomide-C2-acid
|
Others | Others |
Pomalidomide-C2-acid 是 PROTAC 的组成部分。 | |||
T40000 |
Pomalidomide-C3-I
|
Others | Others |
Pomalidomide-C3-I 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40004 |
Pomalidomide-C7-NH2 hydrochloride
|
Others | Others |
Pomalidomide-C7-NH2 hydrochloride 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40008 |
Pomalidomide-C6-I TFA
|
Others | Others |
Pomalidomide-C6-I TFA 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40015 |
Pomalidomide-PEG2-NH2 hydrochloride
|
Others | Others |
Pomalidomide-PEG2-NH2 hydrochloride 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40023 |
Pomalidomide-PEG3-CO2H
Thalidomide-NH-PEG3-propionic acid |
E3 Ligase Ligand-Linker Conjugate | PROTAC |
Pomalidomide-PEG3-CO2H (Thalidomide-NH-PEG3-propionic acid) 是一种由 E3 连接酶配体和连接体组成的偶联物,结合了基于 Thalidomide 的 Cereblon 配体和 3 个单元 PEG Linker。 | |||
T9387 |
Pomalidomide 4'-PEG2-azide
|
E3 Ligase Ligand-Linker Conjugate | PROTAC |
Pomalidomide 4'-PEG2-azide 是由E3 连接酶配体和linker 组成的偶联物,包括基于 Pomalidomide 的 cereblon 配体和linker。 | |||
T40006 |
Pomalidomide-CH2CONH-C2-COOH
|
Others | Others |
Pomalidomide-CH2CONH-C2-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T40002 |
Pomalidomide-C3-NH2 hydrochloride
|
Others; E3 Ligase Ligand-Linker Conjugate | Others; PROTAC |
Pomalidomide-C3-NH2 hydrochloride 包含基于 Pomalidomide 的 cereblon 配体和 1 个 linker,是合成的 E3 连接酶配体-linker 偶联物,可用于 PROTAC 的合成。 | |||
T7761 |
Pomalidomide-C2-NH2 hydrochloride
|
E3 Ligase Ligand-Linker Conjugate; Ligand for E3 Ligase | PROTAC |
Pomalidomide-C2-NH2 hydrochloride 包含基于 Pomalidomide 的 cereblon 配体和 1 个 linker,是合成的 E3 连接酶配体-linker 偶联物。 | |||
T40032 |
Pomalidomide-PEG4-C2-NH2 hydrochloride
|
PROTAC Linker | PROTAC |
Pomalidomide-PEG4-C2-NH2 hydrochloride 是 E3 连接酶配体和 linker 组成的 偶联物,包含基于 Pomalidomide 的 cereblon 配体和 4 个单元 PEG 的 linker,可用于 PROTAC 分子的合成。 | |||
T17325 |
Pomalidomide-PEG4-C-COOH
Cereblon Ligand -Linker Conjugates 1,E3 Ligase Ligand-Linker Conjugates 1 |
Others; E3 Ligase Ligand-Linker Conjugate | Others; PROTAC |
Pomalidomide-PEG4-C-COOH (E3 Ligase Ligand-Linker Conjugates 1) 包含基于 Pomalidomide 的 cereblon 配体和 4 个单元 PEG linker,是一种合成的 E3 连接酶配体-linker 偶联物。 | |||
T9383 |
Pomalidomide-PEG2-OH
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]- |
PROTACs | PROTAC |
Pomalidomide-PEG2-OH 能够合成用于靶向蛋白质降解和 PROTAC(蛋白水解靶向嵌合体)技术的分子。 | |||
T9384 |
Pomalidomide-PEG3-OH
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]amino]- |
PROTACs | PROTAC |
Pomalidomide-PEG3-OH 能够合成用于靶向蛋白质降解和 PROTAC(蛋白水解靶向嵌合体)技术的分子。 | |||
T17916 |
Pomalidomide-PEG4-C2-NH2
Cereblon Ligand-Linker Conjugates 8,E3 Ligase Ligand-Linker Conjugates 22 |
Others; Ligand for E3 Ligase | Others; PROTAC |
Pomalidomide-PEG4-C2-NH2 (E3 Ligase Ligand-Linker Conjugates 22) 是一种合成的 E3 连接酶配体- linker 偶联物,用于 PROTAC 技术中。 | |||
T7756 |
Pomalidomide-PEG4-Ph-NH2
|
Ligand for E3 Ligase | PROTAC |
Pomalidomide-PEG4-Ph-NH2 是一种合成的 E3 连接酶配体- linker 偶联物,结合了基于 Pomalidomide 的 cereblon 配体和 4 单元 PEG linker。 | |||
T39804 |
Pomalidomide-PEG3-azide
Pomalidomide-PEG3-azide |
||
Pomalidomide-PEG3-azide is a chemically synthesized conjugate comprised of a cereblon ligand based on Pomalidomide, an E3 ligase ligand-linker, and a 3-unit PEG linker. This conjugate is specifically designed for use in PROTAC technology. | |||
T41163 |
ZNL 02-096
Pomalidomide-C3-adavosertib |
Apoptosis; Wee1 | Apoptosis; Cell Cycle/Checkpoint |
ZNL 02-096 (Pomalidomide-C3-adavosertib) 是一种快速和选择性的 Wee1 降解剂 (IC50=3.58 nM)。ZNL 02-096 可在亚摩尔浓度下选择性降解 Wee1,而不损伤 AZD 1775 的二级靶点 PLK1。在体外 MOLT-4 细胞中,ZNL 02-096 可诱导 Wee1 降解、DNA 损伤积累、细胞周期停滞在 G2/M 期和细胞凋亡。ZNL 02-096 在 300 种癌症细胞系中显示出抗增殖作用。 | |||
T39803 |
Pomalidomide-PEG2-azide
Pomalidomide-PEG2-azide |
||
Pomalidomide-PEG2-azide is a synthetic conjugate consisting of a cereblon ligand derived from Pomalidomide and a 2-unit PEG linker, designed for use in PROTAC technology as a ligand-linker conjugate of E3 ligase. | |||
T39701 |
Pomalidomide-C7-COOH
Pomalidomide-C7-COOH |
||
Pomalidomide-C7-COOH is a chemically synthesized E3 ligase cereblon ligand-linker conjugate, utilized as an intermediate compound for the synthesis of PROTAC BCL-XL degraders. | |||
T39381 |
Pomalidomide-C4-NH2
Pomalidomide-C4-NH2 |
||
Pomalidomide-C4-NH2 is a chemically synthesized conjugate, consisting of a ligand for E3 ligase (cereblon) derived from Pomalidomide and a linker employed in PROTAC technology. | |||
T39032 |
Pomalidomide-5-O-CH3
Pomalidomide-5-O-CH3 |
||
Pomalidomide-5-O-CH3, a derivative of Pomalidomide, serves as a specific ligand for cereblon (CRBN) protein recruitment. It can be linked to the protein ligand to create a PROTAC. | |||
T40085 |
Pomalidomide-amino-PEG5-NH2 hydrochloride
Pomalidomide-amino-PEG5-NH2 hydrochloride |
||
Pomalidomide-amino-PEG5-NH2 hydrochloride is a chemical compound that has been synthesized as an E3 ligase ligand-linker conjugate. This compound combines a Pomalidomide-based cereblon ligand with a linker commonly used in PROTAC technology. | |||
T39636 |
Pomalidomide-C4-NH2 hydrochloride
Pomalidomide-C4-NH2 hydrochloride |
||
Pomalidomide-C4-NH2 hydrochloride is a synthesized conjugate comprising an E3 ligase ligand-linker. This compound incorporates the cereblon ligand derived from Pomalidomide and a linker that is commonly employed in PROTAC technology. | |||
T39806 |
Pomalidomide 4'-PEG3-azide
Pomalidomide 4'-PEG3-azide |
||
Pomalidomide 4'-PEG3-azide is a chemically synthesized conjugate consisting of an E3 ligase ligand-linker conjugate that incorporates the cereblon ligand derived from Pomalidomide, along with a linker. This compound, Pomalidomide 4'-PEG3-azide, is utilized in the synthesis of iRucaparib-TP3 (Compound 3). iRucaparib-TP3, developed through the PROTAC strategy, is an effective degrader of PARP1, derived from Rucaparib. | |||
T39637 |
Pomalidomide-amido-C3-COOH
Pomalidomide-amido-C3-COOH |
||
Pomalidomide-amido-C3-COOH is a conjugate compound synthesized as an E3 ligase ligand-linker. It combines a cereblon ligand derived from Pomalidomide with a linker, both of which are used in PROTAC technology. | |||
T36263 |
Pomalidomide 4'-alkylC8-acid
Pomalidomide 4'-alkylC8-acid |
||
Functionalized cereblon ligand for PROTAC research and development; incorporates an E3 ligase ligand plus an alkylC8 linker with terminal acid ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license. | |||
T39033 |
Pomalidomide-6-O-CH3
Pomalidomide-6-O-CH3 |
||
Pomalidomide-6-O-CH3 is a Pomalidomide-derived ligand for cereblon (CRBN), which serves as a linkage agent to recruit the CRBN protein. This ligand, when connected to a protein via a linker, enables the formation of PROTAC. | |||
T40084 |
Pomalidomide-amino-PEG5-NH2
Pomalidomide-amino-PEG5-NH2 |
||
Pomalidomide-amino-PEG5-NH2 is a synthesized conjugate combining the Pomalidomide-based cereblon ligand and a linker utilized in PROTAC technology. It acts as an E3 ligase ligand-linker conjugate. | |||
T39866 |
Pomalidomide-amino-PEG4-NH2
Pomalidomide-amino-PEG4-NH2 |
||
Pomalidomide-amino-PEG4-NH2 is a conjugate compound that combines the Pomalidomide-based cereblon ligand and a linker, effectively functioning as a synthesized E3 ligase ligand-linker conjugate utilized in PROTAC technology. | |||
T39952 |
Pomalidomide-amino-PEG3-NH2
Pomalidomide-amino-PEG3-NH2 |
||
Pomalidomide-amino-PEG3-NH2 is a compound obtained through synthesis, consisting of a conjugation between the E3 ligase ligand linker and Pomalidomide, a cereblon ligand. This compound is specifically designed for application in PROTAC technology, incorporating a linker that enables effective binding with the targeted proteins. | |||
T39875 |
Pomalidomide-PEG6-NH2 hydrochloride
Pomalidomide-PEG6-NH2 hydrochloride |
||
Pomalidomide-PEG6-NH2 hydrochloride is a compound resulting from the synthesis of an E3 ligase ligand-linker conjugate. It combines the cereblon ligand derived from Pomalidomide with a 6-unit PEG linker. This compound is specifically designed for application in PROTAC technology. | |||
T39953 |
Pomalidomide-amino-PEG3-NH2 hydrochloride
Pomalidomide-amino-PEG3-NH2 hydrochloride |
||
Pomalidomide-amino-PEG3-NH2 hydrochloride is a synthetic conjugate compound incorporating the cereblon ligand from Pomalidomide and a linker commonly utilized in PROTAC technology. This compound functions as an E3 ligase ligand-linker conjugate in biochemical reactions. | |||
T39867 |
Pomalidomide-amino-PEG4-NH2 hydrochloride
Pomalidomide-amino-PEG4-NH2 hydrochloride |
||
Pomalidomide-amino-PEG4-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, incorporates the cereblon ligand derived from Pomalidomide, along with a linker commonly employed in PROTAC technology. | |||
T40078 | (R)-Pomalidomide-pyrrolidine | ||
(R)-Pomalidomide-pyrrolidine, a CRBN ligand, can be conjugated to a protein-targeting ligand via a linker, resulting in the formation of PROTACs. | |||
T40105 |
Pomalidomide-PEG3-C2-NH2 hydrochloride
Pomalidomide-PEG3-C2-NH2 hydrochloride,Cereblon Ligand-Linker Conjugates 5 hydrochloride,E3ligaseLigand-LinkerConjugates30hydrochloride |
||
Pomalidomide-PEG3-C2-NH2 hydrochloride, also known as Cereblon Ligand-Linker Conjugate 5, is a chemically synthesized E3 ligase ligand-linker conjugate. This compound incorporates a cereblon ligand based on Pomalidomide and a linker commonly employed in PROTAC technology. | |||
T30772 |
Pomalidomide-5-OH
CC-17368,MVWWLCCKVBTYTD-UHFFFAOYSA-N,CC 17368,Pomalidomide metabolite M17,SCHEMBL15439650,CC17368 |
||
CC-17368 is a bio-active chemical. | |||
T69989 | (S)-Pomalidomide | ||
(S)-Pomalidomide is an inhibitor of angiogenesis and growth of B-cell neoplasias, which induces complete regressions of Burkitt's lymphoma cell tumors. | |||
T40010 | Pomalidomide-C9-COOH | Others | Others |
Pomalidomide-C9-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | |||
T18554 |
Pomalidomide-PEG1-azide
|
Others | Others |
Pomalidomide-PEG1-azide is an E3 ligase ligand-linker conjugate that combines the cereblon ligand based on Pomalidomide with a linker. This compound is instrumental in designing PROTAC BRD4 Degrader-1[1]. | |||
T18556 | Pomalidomide-PEG4-azide | Others | Others |
Pomalidomide-PEG4-azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | |||
T36262 |
Thalidomide-NH-C5-NH2 hydrochloride
Pomalidomide 4'-alkylC5-amine |
||
Functionalized cereblon ligand for PROTAC research and development; incorporates an E3 ligase ligand plus an alkylC5 linker with terminal amine ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. This product has been recently renamed. The previous name for this product was Pomalidomide - linker 4 PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license. |